Compare GSK Consumer with AVANTI FEEDS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs AVANTI FEEDS - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER AVANTI FEEDS GSK CONSUMER/
AVANTI FEEDS
 
P/E (TTM) x 39.1 14.8 264.0% View Chart
P/BV x 11.0 5.2 210.8% View Chart
Dividend Yield % 1.0 0.9 113.2%  

Financials

 GSK CONSUMER   AVANTI FEEDS
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
AVANTI FEEDS
Mar-19
GSK CONSUMER/
AVANTI FEEDS
5-Yr Chart
Click to enlarge
High Rs7,8192,525 309.7%   
Low Rs5,832306 1,905.8%   
Sales per share (Unadj.) Rs1,136.92,560.8 44.4%  
Earnings per share (Unadj.) Rs233.7225.1 103.8%  
Cash flow per share (Unadj.) Rs248.1251.4 98.7%  
Dividends per share (Unadj.) Rs105.004.00 2,625.0%  
Dividend yield (eoy) %1.50.3 544.4%  
Book value per share (Unadj.) Rs973.5885.4 109.9%  
Shares outstanding (eoy) m42.0613.62 308.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.00.6 1,086.1%   
Avg P/E ratio x29.26.3 464.6%  
P/CF ratio (eoy) x27.55.6 488.8%  
Price / Book Value ratio x7.01.6 438.6%  
Dividend payout %44.91.8 2,529.1%   
Avg Mkt Cap Rs m287,08319,279 1,489.1%   
No. of employees `0003.81.0 381.3%   
Total wages/salary Rs m6,4461,003 642.6%   
Avg. sales/employee Rs Th12,440.234,601.0 36.0%   
Avg. wages/employee Rs Th1,677.0995.2 168.5%   
Avg. net profit/employee Rs Th2,556.73,042.0 84.0%   
INCOME DATA
Net Sales Rs m47,82034,878 137.1%  
Other income Rs m4,326538 803.6%   
Total revenues Rs m52,14635,416 147.2%   
Gross profit Rs m11,4104,073 280.2%  
Depreciation Rs m606358 168.9%   
Interest Rs m826 29.7%   
Profit before tax Rs m15,1234,226 357.8%   
Minority Interest Rs m03 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m052 0.0%   
Tax Rs m5,2951,214 436.0%   
Profit after tax Rs m9,8283,066 320.5%  
Gross profit margin %23.911.7 204.3%  
Effective tax rate %35.028.7 121.9%   
Net profit margin %20.68.8 233.8%  
BALANCE SHEET DATA
Current assets Rs m52,67411,795 446.6%   
Current liabilities Rs m18,1402,199 824.7%   
Net working cap to sales %72.227.5 262.5%  
Current ratio x2.95.4 54.1%  
Inventory Days Days3640 89.6%  
Debtors Days Days295 578.3%  
Net fixed assets Rs m4,7983,330 144.1%   
Share capital Rs m421136 308.8%   
"Free" reserves Rs m40,52711,923 339.9%   
Net worth Rs m40,94712,060 339.5%   
Long term debt Rs m011 0.0%   
Total assets Rs m60,68116,148 375.8%  
Interest coverage x1,939.8161.7 1,199.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.82.2 36.5%   
Return on assets %16.219.2 84.6%  
Return on equity %24.025.4 94.4%  
Return on capital %37.035.7 103.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,17116 20,313.2%   
Fx outflow Rs m1,7701,486 119.1%   
Net fx Rs m1,401-1,470 -95.3%   
CASH FLOW
From Operations Rs m6,7111,838 365.2%  
From Investments Rs m-3,351-268 1,251.2%  
From Financial Activity Rs m-3,768-1,058 356.2%  
Net Cashflow Rs m-408512 -79.6%  

Share Holding

Indian Promoters % 0.0 44.2 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 2.8 28.6%  
FIIs % 12.0 3.2 375.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 0.0 -  
Shareholders   26,457 8,560 309.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   GOODRICKE  VADILAL INDUSTRIES  NESTLE  RASOYA PROTEINS  SANWARIA CONSUMER  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

India Top US Crude Oil Buyer in Q1CY21, Adani Ports Removed from S&P Index, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note on Tuesday. Benchmark indices extended gains after the Indian government fast-tracked emergency approvals for foreign produced Covid-19 vaccines.

Related Views on News

AVANTI FEEDS Announces Quarterly Results (3QFY21); Net Profit Up 47.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AVANTI FEEDS has posted a net profit of Rs 869 m (up 47.2% YoY). Sales on the other hand came in at Rs 9 bn (down 0.8% YoY). Read on for a complete analysis of AVANTI FEEDS's quarterly results.

AVANTI FEEDS Announces Quarterly Results (1QFY21); Net Profit Up 14.1% (Quarterly Result Update)

Aug 28, 2020 | Updated on Aug 28, 2020

For the quarter ended June 2020, AVANTI FEEDS has posted a net profit of Rs 1 bn (up 14.1% YoY). Sales on the other hand came in at Rs 10 bn (down 12.6% YoY). Read on for a complete analysis of AVANTI FEEDS's quarterly results.

Burger King IPO: Should You Subscribe to This QSR Chain Business? (IPO)

Dec 2, 2020

Does the company with one of the fastest-growing QSR chains in India have sound prospects?

AVANTI FEEDS Announces Quarterly Results (4QFY20); Net Profit Up 29.2% (Quarterly Result Update)

Jun 29, 2020 | Updated on Jun 29, 2020

For the quarter ended March 2020, AVANTI FEEDS has posted a net profit of Rs 987 m (up 29.2% YoY). Sales on the other hand came in at Rs 10 bn (up 20.7% YoY). Read on for a complete analysis of AVANTI FEEDS's quarterly results.

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday(Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS